Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (276K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (81)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Koeppel, F.
Right arrow Articles by Mergny, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koeppel, F.
Right arrow Articles by Mergny, J.-L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2001, Vol. 29, No. 5 1087-1096
© 2001 Oxford University Press

Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes

Florence Koeppel, Jean-François Riou1, Abdelazize Laoui1, Patrick Mailliet1, Paola B. Arimondo, Delphine Labit, Odile Petitgenet1, Claude Hélène and Jean-Louis Mergny*

Laboratoire de Biophysique, Muséum National d’Histoire Naturelle, INSERM U201, CNRS UMR 8646, 43 rue Cuvier, 75005 Paris, France and 1Centre de Recherche de Vitry-Alfortville, Aventis-Pharma S.A., 94400 Vitry-sur-Seine Cedex, France

The telomeric G-rich single-stranded DNA can adopt in vitro an intramolecular quadruplex structure, which has been shown to directly inhibit telomerase activity. The reactivation of this enzyme in immortalized and most cancer cells suggests that telomerase is a relevant target in oncology, and telomerase inhibitors have been proposed as new potential anticancer agents. In this paper, we describe ethidium derivatives that stabilize G-quadruplexes. These molecules were shown to increase the melting temperature of an intramolecular quadruplex structure, as shown by fluorescence and absorbance measurements, and to facilitate the formation of intermolecular quadruplex structures. In addition, these molecules may be used to reveal the formation of multi-stranded DNA structures by standard fluorescence imaging, and therefore become fluorescent probes of quadruplex structures. This recognition was associated with telomerase inhibition in vitro: these derivatives showed a potent anti-telomerase activity, with IC50 values of 18–100 nM in a standard TRAP assay.

* To whom correspondence should be addressed. Tel: +33 1 40 79 36 89; Fax: +33 1 40 79 37 05; Email: mergny{at}vnumail.com Present addresses Paola B. Arimondo, UMR 176 CNRS, Institut Curie, Section Recherche, 26 rue d’Ulm, 75005 Paris, France Jean-Francois Riou, Unité MéDIAN CNRS FRE 2141, UFR de pharmacie Université de Reims, France


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
A. N. Lane, J. B. Chaires, R. D. Gray, and J. O. Trent
Stability and kinetics of G-quadruplex structures
Nucleic Acids Res., August 21, 2008; (2008) gkn517v1.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Brassart, D. Gomez, A. D. Cian, R. Paterski, A. Montagnac, K.-H. Qui, N. Temime-Smaali, C. Trentesaux, J.-L. Mergny, F. Gueritte, et al.
A New Steroid Derivative Stabilizes G-Quadruplexes and Induces Telomere Uncapping in Human Tumor Cells
Mol. Pharmacol., September 1, 2007; 72(3): 631 - 640.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. M. Barbieri, A. R. Srinivasan, S. G. Rzuczek, J. E. Rice, E. J. LaVoie, and D. S. Pilch
Defining the mode, energetics and specificity with which a macrocyclic hexaoxazole binds to human telomeric G-quadruplex DNA
Nucleic Acids Res., May 11, 2007; 35(10): 3272 - 3286.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. D. Cian and J.-L. Mergny
Quadruplex ligands may act as molecular chaperones for tetramolecular quadruplex formation
Nucleic Acids Res., April 3, 2007; 35(8): 2483 - 2493.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Gomez, T. Wenner, B. Brassart, C. Douarre, M.-F. O'Donohue, V. El Khoury, K. Shin-ya, H. Morjani, C. Trentesaux, and J.-F. Riou
Telomestatin-induced Telomere Uncapping Is Modulated by POT1 through G-overhang Extension in HT1080 Human Tumor Cells
J. Biol. Chem., December 15, 2006; 281(50): 38721 - 38729.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Y. He, R. D. Neumann, and I. G. Panyutin
Intramolecular quadruplex conformation of human telomeric DNA assessed with 125I-radioprobing
Nucleic Acids Res., October 8, 2004; 32(18): 5359 - 5367.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
A. Biroccio and C. Leonetti
Telomerase as a new target for the treatment of hormone-refractory prostate cancer
Endocr. Relat. Cancer, September 1, 2004; 11(3): 407 - 421.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
W. C. Hahn
Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer
J. Clin. Oncol., May 15, 2003; 21(10): 2034 - 2043.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. H. Thorpe, S. C. M. Teixeira, B. C. Gale, and C. J. Cardin
Crystal structure of the complementary quadruplex formed by d(GCATGCT) at atomic resolution
Nucleic Acids Res., February 1, 2003; 31(3): 844 - 849.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. M. Gowan, J. R. Harrison, L. Patterson, M. Valenti, M. A. Read, S. Neidle, and L. R. Kelland
A G-Quadruplex-Interactive Potent Small-Molecule Inhibitor of Telomerase Exhibiting in Vitro and in Vivo Antitumor Activity
Mol. Pharmacol., May 1, 2002; 61(5): 1154 - 1162.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J.-L. Mergny, J.-F. Riou, P. Mailliet, M.-P. Teulade-Fichou, and E. Gilson
Natural and pharmacological regulation of telomerase
Nucleic Acids Res., February 15, 2002; 30(4): 839 - 865.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. F. Riou, L. Guittat, P. Mailliet, A. Laoui, E. Renou, O. Petitgenet, F. Megnin-Chanet, C. Helene, and J. L. Mergny
Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands
PNAS, February 14, 2002; (2002) 52698099.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
W. Duan, A. Rangan, H. Vankayalapati, M.-Y. Kim, Q. Zeng, D. Sun, H. Han, O. Yu. Fedoroff, D. Nishioka, S. Y. Rha, et al.
Design and Synthesis of Fluoroquinophenoxazines That Interact with Human Telomeric G-Quadruplexes and Their Biological Effects
Mol. Cancer Ther., December 1, 2001; 1(2): 103 - 120.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. M. Gowan, R. Heald, M. F. G. Stevens, and L. R. Kelland
Potent Inhibition of Telomerase by Small-Molecule Pentacyclic Acridines Capable of Interacting with G-Quadruplexes
Mol. Pharmacol., November 1, 2001; 60(5): 981 - 988.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J.-L. Mergny, L. Lacroix, M.-P. Teulade-Fichou, C. Hounsou, L. Guittat, M. Hoarau, P. B. Arimondo, J.-P. Vigneron, J.-M. Lehn, J.-F. Riou, et al.
Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay
PNAS, March 13, 2001; 98(6): 3062 - 3067.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. F. Riou, L. Guittat, P. Mailliet, A. Laoui, E. Renou, O. Petitgenet, F. Megnin-Chanet, C. Helene, and J. L. Mergny
Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands
PNAS, March 5, 2002; 99(5): 2672 - 2677.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.